购物车里没有产品

Anti-TNFAIP3 antibody

产品货号 产品 品牌 单位 存货 价格 促销价 数量  
AB-06-4393
Anti-TNFAIP3 antibody
洱畔/Erpan Tech 有货

产品特性        

Product Cat#: AB-06-4393
Product type: Primary antibody
Antigen: TNFAIP3
Immunogen: Recombinant protein
Species immunized: Rabbit
Isotype: IgG
Applications: Western Blot (1:800); Immunohistochemistry (1:40-1:200); Flow Cytometry (1:40-1:100); Immunocytochemistry (1:0-1:500); Immunofluorescence
Reactivity: Human, Mouse, Rat
Clonality (clone number): Monoclonal (SN07-31)
Form: Liquid
Buffer: Tris-HCl buffer (pH 7.4), 1% BSA, 40% glycerol, 0.05% NaN3.
Concentration: 1 mg/ml
Purity: Protein A affinity purified
Storage: Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles.
Alternative names: A20 antibody
AISBL antibody
MGC104522 antibody
MGC138687 antibody
MGC138688 antibody
OTU domain containing protein 7C antibody
OTU domain-containing protein 7C antibody
OTUD7C antibody
Putative DNA binding protein A20 antibody
Putative DNA-binding protein A20 antibody
TNAP3_HUMAN antibody
TNF alpha-induced protein 3 antibody
TNFA1P2 antibody
TNFAIP 3 antibody
TNFAIP3 (A20) antibody
TNFAIP3 antibody
Tumor necrosis factor alpha induced protein 3 antibody
Tumor necrosis factor alpha-induced protein 3 antibody
Tumor necrosis factor induced protein 3 antibody
Tumor necrosis factor inducible protein A20 antibody
Tumor necrosis factor, alpha-induced protein 3 antibody
Zinc finger protein A20 antibody
展开

靶标信息

Ubiquitin-editing enzyme that contains both ubiquitin ligase and deubiquitinase activities. Involved in immune and inflammatory responses signaled by cytokines, such as TNF-alpha and IL-1 beta, or pathogens via Toll-like receptors (TLRs) through terminating NF-kappa-B activity. Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. In cooperation with TAX1BP1 promotes disassembly of E2-E3 ubiquitin protein ligase complexes in IL-1R and TNFR-1 pathways; affected are at least E3 ligases TRAF6, TRAF2 and BIRC2, and E2 ubiquitin-conjugating enzymes UBE2N and UBE2D3. In cooperation with TAX1BP1 promotes ubiquitination of UBE2N and proteasomal degradation of UBE2N and UBE2D3. Upon TNF stimulation, deubiquitinates ‘Lys-63’-polyubiquitin chains on RIPK1 and catalyzes the formation of ‘Lys-48’-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Deubiquitinates TRAF6 probably acting on ‘Lys-63’-linked polyubiquitin. Upon T-cell receptor (TCR)-mediated T-cell activation, deubiquitinates ‘Lys-63’-polyubiquitin chains on MALT1 thereby mediating disassociation of the CBM (CARD11:BCL10:MALT1) and IKK complexes and preventing sustained IKK activation. Deubiquitinates NEMO/IKBKG; the function is facilitated by TNIP1 and leads to inhibition of NF-kappa-B activation. Upon stimulation by bacterial peptidoglycans, probably deubiquitinates RIPK2. Can also inhibit I-kappa-B-kinase (IKK) through a non-catalytic mechanism which involves polyubiquitin; polyubiquitin promotes association with IKBKG and prevents IKK MAP3K7-mediated phosphorylation. Targets TRAF2 for lysosomal degradation. In vitro able to deubiquitinate ‘Lys-11’-, ‘Lys-48’- and ‘Lys-63’ polyubiquitin chains. Inhibitor of programmed cell death. Has a role in the function of the lymphoid system. Required for LPS-induced production of proinflammatory cytokines and IFN beta in LPS-tolerized macrophages.

产品来源

洱畔科技实验室

文件下载

MSDS-AB-06-4393.pdf (下载127 )